On 13 April 2025, our third site investigator meeting convened 16 representatives from 11 sites across five countries, along with members of the Co-Coordination team (P95 and FISABIO) and pharmaceutical partners, at the Zoku Hotel in Vienna, Austria.
The event was organized in parallel of the ESCMID 2025 conference. The full-day session focused on fostering collaboration between partners, co-coordinators, and sites to strengthen the network. It provided a valuable opportunity for participants to connect, share insights, and align on the progress of our partnership and studies.
The co-coordinators presented updates on patient recruitment, progress of the three ongoing studies, and key takeaways from the 2024–2025 season including issues and lessons learned. Additionally, preparations for the upcoming 2025–2026 season were discussed.
The meeting featured robust scientific discussions and served as a platform for knowledge exchange. Participants engaged in open dialogue, sharing lessons learned and experiences from their respective sites, contributing to a collaborative and productive meeting.
We thank all participants for their active involvement and look forward to continued success together.